Skip to main content
Equibles

Brian Lenz

CFO

Adma Biologics, Inc. (ADMA)
Adma Biologics, Inc. (ADMA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Brian Lenz

Brian Lenz is recorded as CFO at Adma Biologics, Inc. (ADMA). The proxy statement of Adma Biologics, Inc. reports total compensation of $1,965,360 for Brian Lenz in fiscal 2023, including a base salary of $475,000. Disclosed compensation is on record for 6 fiscal years. Brian Lenz has spoken on 16 earnings calls across 1 company, most recently for Adma Biologics, Inc. on May 9, 2024.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Adma Biologics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Adma Biologics, Inc. (ADMA) $475,000 $1,965,360
2022 Adma Biologics, Inc. (ADMA) $445,578 $1,601,064
2021 Adma Biologics, Inc. (ADMA) $432,600 $2,366,680
2020 Adma Biologics, Inc. (ADMA) $420,000 $1,087,018
2019 Adma Biologics, Inc. (ADMA) $390,000 $1,122,154
2018 Adma Biologics, Inc. (ADMA) $366,800 $940,094

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 4 earlier activities